CYP2D6 and atrial fibrillation: This study set out to investigate whether the identification of gene profiles can guide the retarding treatment in the acute period by analyzing the association between the efficacy of diltiazem and the genetic polymorphism of CYP2D6 in patients admitted into ED for various reasons and diagnosed with AF with RVR after electrocardiographic examination of their heart rhythms.